Clinical trial

Apathy in Dementia Methylphenidate Trial (ADMET)

NCT01117181

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-01

PhasePHASE2

Study timeline

Study start (unknown)2010-06-01Date precision: month

Registry last updated2018-06-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Apathyunresolved

Alzheimer's Diseaseunresolved

Interventions

MethylphenidateDRUG · verified · RxNorm: methylphenidate

Psychosocial interventionOTHER

Sponsors & collaborators

Johns Hopkins Bloomberg School of Public Healthlead sponsor

National Institute on Aging (NIA)collaborator

Medical University of South Carolinacollaborator

Johns Hopkins Universitycollaborator

University of Torontocollaborator

Mapped research locations

BaltimoreMaryland, United States1 TorontoOntario, Canada1 CharlestonSouth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01117181 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.